Pharmacological investigations with different protein kinase C inhibitors on IgE-dependent and IgE-independent activation of human basophils
- PMID: 7506863
- DOI: 10.1007/BF01975708
Pharmacological investigations with different protein kinase C inhibitors on IgE-dependent and IgE-independent activation of human basophils
Abstract
In the present study different selective inhibitors of the multifunctional serine/threonine kinase protein kinase C (PKC) were investigated on classical activation pathways of basophils in comparison to the nonselective protein kinase inhibitor staurosporine. The potent inhibitors Ro 31-7549, Ro 31-8220, calphostin C and ilmofosine (BM 41.440), which show selectivity for PKC in vitro, significantly potentiated Fc epsilon RI-mediated histamine release up to 50% vs. controls at concentrations > 10(-7) mumol/l but were without any intrinsic histamine releasing activity. Direct activation of cellular PKC by phorbol ester was suppressed by all compounds apart from ilmofosine at the same concentrations. We did not observe statistically significant effects of selective PKC inhibitors on exocytosis induced by the peptide formylmeth-leu-phe (FMLP) or the ionophore A23187, whereas staurosporine potentiated the FMLP-induced histamine release in a dose-dependent fashion: maximum potentiation was 63.5 +/- 8.9% vs. control at 1 mumol/l (n = 4). The findings suggest that PKC exhibits differential functions during biochemical events of stimulus-secretion coupling in human basophils supposedly by its distinct subtypes. With respect to the present data, TPA-induced and IgE-mediated signals are not closely correlated.
Similar articles
-
Investigations with the selective PKC inhibitor chelerythrine on human basophils.Agents Actions. 1994 Jun;41 Spec No:C56-7. doi: 10.1007/BF02007765. Agents Actions. 1994. PMID: 7526660
-
Signal transduction events in human basophils. A comparative study of the role of protein kinase C in basophils activated by anti-IgE antibody and formyl-methionyl-leucyl-phenylalanine.J Immunol. 1990 Sep 15;145(6):1897-905. J Immunol. 1990. PMID: 1697313
-
Differential activation of human basophils by anti-IgE and formyl-methionyl-leucyl-phenylalanine. Indications for protein kinase C-dependent and -independent activation pathways.Eur J Immunol. 1991 Apr;21(4):881-5. doi: 10.1002/eji.1830210404. Eur J Immunol. 1991. PMID: 1708341
-
CGP 41251, a novel protein kinase inhibitor with in vitro selectivity for protein kinase C, strongly inhibits immunological activation of human skin mast cells and human basophils.Pharmacology. 1993 Sep;47(3):200-8. doi: 10.1159/000139098. Pharmacology. 1993. PMID: 7692457
-
Modulation of human basophil histamine release by protein kinase C inhibitors differs with secretagogue and with inhibitor.J Pharmacol Exp Ther. 1992 Mar;260(3):1028-37. J Pharmacol Exp Ther. 1992. PMID: 1372047
Cited by
-
Investigations with the selective PKC inhibitor chelerythrine on human basophils.Agents Actions. 1994 Jun;41 Spec No:C56-7. doi: 10.1007/BF02007765. Agents Actions. 1994. PMID: 7526660
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials